“…Solid tumors grow in part by secreting angiogenic factors that promote neovascular ization, thus supplying the tumor with oxygen, nutrients and growth factors [2][3][4], Tumor metastasis is a multistep process that also includes angiogenesis [5,6]. Recently, we could achieve inhibition of tumor growth and metastasis outcome using an inhibitor of tumor-and lymphocyteinduced angiogenesis [7], It is well known that when immunocompetent lympho cytes are injected intradermally into allogeneic mice, they evoke a complex angiogenic response called 'lymphocyteinduced angiogenesis' [8], Activated lymphocytes release soluble mediators (lymphokines) that may act directly on endothelial cells or indirectly on macrophages, being the appropriate stimulus for host endothelial response, thus acting as angiogenic factors [9,10], We have previously demonstrated that spleen lymphocytes from tumor-bear ing mice induced a strong neovascular response even in syngeneic combination (SLIA) [11], Subsequently we re ported that T lymphocytes were the main spleen popula tion responsible for this neovascular response [12].…”